| [1] | Herszényi L,Hritz I,Lakatos G,et al.The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer[J].Int J Mol Sci,2012,13(10):13240-13263. |
| [2] | Martinez-Poveda B,Chavarria T,Sanchez-Jimenez F,et al.An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion[J].Biochem Biophys Res Commun,2003,311(3):649-653. |
| [3] | Murray GI.Matrix metalloproteinases:a multifunctional group of molecules[J].J Pathol,2001,195(2):135. |
| [4] | Chakraborti S,Mandal M,Das S,et al.Regulation of matrix metalloproteinases:an overview[J].Mol Cell Biochem,2003,253(1/2):269-285. |
| [5] | 王小军,杨文平.bFGF、MMPs和TIMPs在肿瘤临床研究中的进展[J].中国现代医药杂志,2012,14(2):126-128. |
| [6] | Sun XM,Dong WG,Yu BP,et al.Detection of type Ⅳ collagenase activity in malignant ascites[J].World J Gastroenterol,2003,9(11):2592-2595. |
| [7] | Murphy G,Willenbrock F,Crabbe T,et al.Regulation of matrix metalloproteinase activity[J].Ann NY Acad Sci,1994,732(1):31. |
| [8] | Brew K,Dinakarpandian D,Nagase H.Tisue inhibitor of metalloproteinases:evolution,structure,and function[J].Biochem Biophys Acta,2000,1477(1):267-283. |
| [9] | Murray GI,Duncan ME,O'Neil P,et al.Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer[J].J Pat hol,1998,185(3):256-261. |